The Open Insulin Project has bigger plans. The group wants to reverse engineer how the world’s largest pharmaceutical companies produce insulin and then turn over the instructions to the public. In ...

Two years ago, California made a bold announcement that it would manufacture a state-branded, low-cost insulin. Drug manufacturers, insurers, economists and diabetics took notice. It had the potential ...

Personalized therapies for diabetes, while showing promise in international studies, is met with healthy skepticism from Louisiana experts. "Maybe in 20 years," a doctor at LSU Health says. Here's ...

Regular (R) insulin is a short-acting, injectable insulin used for the management of diabetes. It is typically taken before meals to prevent glucose from rising after a person eats. Regular insulin is ...